Peptides get their regulatory closeup

A panel of advisers to the Food and Drug Administration will meet this week to make recommendations on whether specialized pharmacies should be allowed to make some popular wellness peptides.

<img src='https://npr.brightspotcdn.com/dims3/default/strip/false/crop/1620x1080+0+0/resize/1620x1080!/?url=http%3A%2F%2Fnpr-brightspot.s3.amazonaws.com%2F8a%2Ffd%2F29a132634dfcaa33c9aadcff6f1b%2Fap25316788276136.jpg' alt='In this image taken from video, an IV infusion is administered at Pure Alchemy Wellness in Chula Vista, Calif., in November 2025.'/><p>A panel of advisers to the Food and Drug Administration will meet this week to make recommendations on whether specialized pharmacies should be allowed to make some popular wellness peptides.</p><p>(Image credit: Javier Arciga)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=nx-s1-5902329' />